Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Prostate Cancer Insight - Profiting From Changing Treatment Patterns' returned 5 results - Page 1 of 1  FEATURED RESULTS Drug Delivery in Cancer - Technologies, Markets and Companies Antibody Drug Target Atlas in Oncology Cancer Diagnostic Testing World Markets Aurora Kinase inhibitors - The dawn of a new approach to cancer Viral Therapy of Cancer   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development   GBI Research, Dec 2011, Pages: 215 Therapeutics Market 5.5 Prostate Cancer Therapeutics Market 5.5.1 Introduction 5.5.2 Survival Rates 5.5.3 Symptoms 5.5.4 Treatment Flow 5.5.5 Revenue 5.5.6 Treatment Usage Patterns 5.5.7 Drivers Top 10 Healthcare Trends in 2011   GBI Research, March 2011, Pages: 194 development findings of innovative treatment for niche segments and the evolution of new cancer segments, cancer therapeutics market continues to attract investments from pharmaceutical companies. 1 1 4 1 Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011   Life Science Intelligence, Inc., Dec 2011, Pages: 605 device for convenient at-home sleep monitoring and analysis to: 1-offer insight into the diagnosis and treatment of conditions such as Alzheimer's, autism, cancer, epilepsy, depression, and schizophrenia The Executive Guide to Molecular Imaging   Espicom Business Intelligence Ltd, July 2007, Pages: 306 treatments declines. When MI reaches its full potential, it will fundamentally change the diagnosis and treatment of disease. Much has happened recently in the field of MI. Many companies have entered Companion Biomarkers in Drug Development   TriMark Publications, April 2009, Pages: 320 .7.5.6 SELDI and Treatment Monitoring 112 3.7.5.7 Limitations of Mass Spectroscopy 112 3.7.6 Partnerships for Developing Proteomic Biomarkers 114 3.7.7 Proteomics in Developing a New Cancer Marker 114 3 Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network